DHG Pharmaceutical JSC (STC:DHG) Cyclically Adjusted FCF per Share: ₫5,059.94 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STC:DHG DHG Pharmaceutical JSC STC:DHG
80 GF Score
Price ₫96,100.00
GF Value ₫113,164.98
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is DHG Pharmaceutical JSC Cyclically Adjusted FCF per Share?

DHG Pharmaceutical JSC STC:DHG +1.26% 80 Cyclically Adjusted FCF per Share is ₫5,059.94 as of Jun. 2026. GuruFocus rates STC:DHG with a GF Score™ of 80/100 and a GF Value™ of ₫113,164.98 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

DHG Pharmaceutical JSC's adjusted free cash flow per share for the three months ended in Jun. 2026 was ₫1,275.831. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₫5,059.94 for the trailing ten years ended in Jun. 2026.

During the past 12 months, DHG Pharmaceutical JSC's average Cyclically Adjusted FCF Growth Rate was 0.60% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 12.50% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 10.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of DHG Pharmaceutical JSC was 12.50% per year. The lowest was 4.20% per year. And the median was 11.40% per year.

As of today (2026-08-25), DHG Pharmaceutical JSC's current stock price is ₫96100.00. DHG Pharmaceutical JSC's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was ₫5,059.94. DHG Pharmaceutical JSC's Cyclically Adjusted Price-to-FCF of today is 18.99.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of DHG Pharmaceutical JSC was 38.65. The lowest was 17.96. And the median was 26.64.


DHG Pharmaceutical JSC  (STC:DHG) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

DHG Pharmaceutical JSC's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=96100.00/5059.94
=18.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of DHG Pharmaceutical JSC was 38.65. The lowest was 17.96. And the median was 26.64.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


DHG Pharmaceutical JSC Cyclically Adjusted FCF per Share Related Terms


DHG Pharmaceutical JSC Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for DHG Pharmaceutical JSC's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DHG Pharmaceutical JSC Cyclically Adjusted FCF per Share Chart

DHG Pharmaceutical JSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,240.88 3,625.89 3,425.63 4,483.90 5,168.59

DHG Pharmaceutical JSC Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,029.44 4,942.34 5,168.59 5,050.58 5,059.94

STC:DHG vs ZTS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, DHG Pharmaceutical JSC's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DHG Pharmaceutical JSC Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DHG Pharmaceutical JSC's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where DHG Pharmaceutical JSC's Cyclically Adjusted Price-to-FCF falls into.


STC:DHG
80GF Score
DHG Pharmaceutical JSC STC:DHG
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DHG Pharmaceutical JSC Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, DHG Pharmaceutical JSC's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1275.831/333.9520*333.9520
=1,275.831

Current CPI (Jun. 2026) = 333.9520.

DHG Pharmaceutical JSC Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 550.455 241.428 761.409
201612 625.205 241.432 864.792
201703 599.364 243.801 820.993
201706 997.440 244.955 1,359.830
201709 781.627 246.819 1,057.560
201712 856.431 246.524 1,160.158
201803 -285.078 249.554 -381.490
201806 1,972.882 251.989 2,614.590
201809 -193.922 252.439 -256.540
201812 175.379 251.233 233.123
201903 898.986 254.202 1,181.022
201906 1,338.769 256.143 1,745.449
201909 1,748.829 256.759 2,274.604
201912 1,859.028 256.974 2,415.910
202003 1,875.778 258.115 2,426.902
202006 -4.432 257.797 -5.741
202009 1,451.098 260.280 1,861.830
202012 2,175.312 260.474 2,788.953
202103 666.164 264.877 839.887
202106 826.599 271.696 1,016.005
202109 1,817.128 274.310 2,212.218
202112 -132.980 278.802 -159.285
202203 1,799.422 287.504 2,090.129
202206 868.035 296.311 978.303
202209 1,296.989 296.808 1,459.301
202212 1,067.628 296.797 1,201.281
202303 -432.780 301.836 -478.829
202306 -524.348 305.109 -573.916
202309 -1,220.345 307.789 -1,324.078
202312 342.506 306.746 372.884
202403 2,686.303 312.332 2,872.252
202406 1,608.778 314.175 1,710.049
202409 1,686.155 315.301 1,785.896
202412 3,199.315 315.605 3,385.300
202503 2,618.622 319.799 2,734.512
202506 2,648.632 322.561 2,742.166
202509 367.876 324.800 378.242
202512 3,201.975 324.054 3,299.777
202603 -140.278 330.213 -141.866
202606 1,275.831 333.952 1,275.831

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ₫5,059.94 mean?
DHG Pharmaceutical JSC (STC:DHG) has a Cyclically Adjusted FCF per Share of ₫5,059.94 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on DHG Pharmaceutical JSC and its competitors.
Is DHG Pharmaceutical JSC's Cyclically Adjusted FCF per Share too high?
DHG Pharmaceutical JSC's current Cyclically Adjusted FCF per Share is ₫5,059.94. Overall, DHG Pharmaceutical JSC has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DHG Pharmaceutical JSC's Cyclically Adjusted FCF per Share compare to ZTS?
DHG Pharmaceutical JSC's Cyclically Adjusted FCF per Share of ₫5,059.94 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on DHG Pharmaceutical JSC and its competitors. DHG Pharmaceutical JSC's current Cyclically Adjusted FCF per Share is ₫5,059.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DHG Pharmaceutical JSC stock overvalued right now?
Based on GuruFocus' analysis, DHG Pharmaceutical JSC (STC:DHG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫113,164.98, compared to a current price of ₫96,100.00 — trading 15.1% below its estimated fair value. The current Cyclically Adjusted FCF per Share is ₫5,059.94. DHG Pharmaceutical JSC's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For DHG Pharmaceutical JSC (STC:DHG), the current Cyclically Adjusted FCF per Share is ₫5,059.94 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DHG Pharmaceutical JSC (STC:DHG) Overvalued in 2026?

Based on GuruFocus' analysis, DHG Pharmaceutical JSC stock appears to be undervalued. The current stock price of ₫96,100.00 is trading 15.1% below its estimated GF Value™ of ₫113,164.98. GuruFocus considers DHG Pharmaceutical JSC to be Modestly Undervalued.

Key valuation signals for STC:DHG:

  • Cyclically Adjusted FCF per Share: ₫5,059.94
  • GF Value™: ₫113,164.98 vs. price of ₫96,100.00 (15.1% below fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the STC:DHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DHG Pharmaceutical JSC Business Description

Address 288 Bis Nguyen Van Cu, An Hoa Ward, Ninh Kieu District, Can Tho, VNM
DHG Pharmaceutical JSC produces and trades in pharmaceutical products. It provides various pharmaceutical products in the areas of antibiotics, antifungals, and antiparasitics; analgesics and antipyretics; ear-nose-throat, cough, and asthma; ophthalmic and nervous system; muscular and osteoarticular; digestive; hepatic; cardiovascular and diabetic; vitamins and minerals; and dermal and beauty care.
80GF Score

Get the complete analysis for STC:DHG

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫96,100.00
Price
₫113,164.98
GF Value